Association between smoking and cognitive impairment in multiple sclerosis

Muhammed Emin Ozcan, Bahri Ince, Ayhan Bingöl, Simge Ertürk, Meriç Adil Altınöz, Hasan Hüseyin Karadeli, Abdulkadir Koçer, Talip Asil, Muhammed Emin Ozcan, Bahri Ince, Ayhan Bingöl, Simge Ertürk, Meriç Adil Altınöz, Hasan Hüseyin Karadeli, Abdulkadir Koçer, Talip Asil

Abstract

Purpose: Although smoking is known to cause various symptoms in multiple sclerosis (MS) patients, there have been no reports regarding the relationship between smoking and cognitive impairment in MS. Studying the effects of cigarette smoking in MS patients is imperative as there is a high prevalence of cognitive impairment in MS patients. In this study we examined the potentially deleterious effects of heavy smoking on mentation of patients with MS.

Patients and methods: MS patients receiving care at the Neurology Clinic at Bezmialem Vakıf University, between the ages of 18-65 years who have at least graduated elementary school were included in the study. The Brief Repeatable Battery of Neuropsychological Tests (BRB-N) is a commonly used method to assess cognitive function in MS patients and was utilized in our study. Patients that smoked for at least 10 pack-years were considered heavy smokers.

Results: ALL THE PATIENTS WERE STRATIFIED INTO TWO GROUPS: heavy smokers (n=20) and nonsmokers (n=24). For heavy smokers, their cognitive functioning was more impaired than that of nonsmokers (P=0.04, χ (2)=4.227). For patients with cognitive impairment, 78.9% of the Paced Auditory Serial Addition Test and 63.2% of the Symbol Digit Modalities Test scores were found to be lower.

Conclusion: Previous reports have suggested that smoking increases the frequency of relapse among individuals with relapsing-remitting MS and accelerates disease progression in patients with progressive MS. According to the results of our study, heavy smokers had increased cognitive impairment when compared to nonsmokers. Extensive studies are necessary to further elucidate the relationship between smoking and cognitive impairment in MS patients.

Keywords: BRB-N; cigarette; cognition; memory; mentation; nicotine; tobacco.

References

    1. Pelosi L, Geesken JM, Holly M, Hayward M, Blumhardt LD. Working memory impairment in early multiple sclerosis. Evidence from an event-related potential study of patients with clinically isolated myelopathy. Brain. 1997;120:2039–2058.
    1. Rao S, Leo G, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis: frequency, patterns, and predictions. Neurology. 1991;41:685–691.
    1. Beatty WM, Blanco CR, Wilbanks SL, Paul RH, Hames KA. Demographic, clinical, and cognitive characteristics of multiple sclerosis patients who continue to work. J Neurol Rehab. 1995;9:167–173.
    1. Pierson SH, Griffith N. Treatment of cognitive impairment in multiple sclerosis. Behav Neurol. 2006;17(1):53–67.
    1. Jafari N, Hintzen RQ. The association between cigarette smoking and multiple sclerosis. J Neurol Sci. 2011;311(1–2):78–85.
    1. Di Pauli F, Reindl M, Ehling R, et al. Smoking is a risk factor for early conversion to clinically definite multiple sclerosis. Mult Scler. 2008;14(8):1026–1030.
    1. D’hooghe MB, Nagels G, Bissay V, De Keyser J. Modifiable factors influencing relapses and disability in multiple sclerosis. Mult Scler. 2010;16(7):773–785.
    1. Pittas F, Ponsonby AL, van der Mei IA, et al. Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis. J Neurol. 2009;256(4):577–585.
    1. Wignall ND, de Wit H. Effects of nicotine on attention and inhibitory control in healthy nonsmokers. Exp Clin Psychopharmacol. 2011;19(3):183–191.
    1. Rusted JM, Sawyer R, Jones C, et al. Positive effects of nicotine on cognition: the deployment of attention for prospective memory. Psychopharmacology (Berl) 2009;202(1–3):93–102.
    1. Ghaffar O, Feinstein A. Multiple sclerosis and cannabis: a cognitive and psychiatric study. Neurology. 2008;71(3):164–169.
    1. Papathanasopoulos P, Messinis L, Lyros E, Kastellakis A, Panagis G. Multiple sclerosis, cannabinoids, and cognition. J Neuropsychiatry Clin Neurosci. 2008;20(1):36–51.
    1. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302.
    1. Friend KB, Mernoff ST, Block P, Reeve G. Smoking rates and smoking cessation among individuals with multiple sclerosis. Disabil Rehabil. 2006;28(18):1135–1141.
    1. Portaccio E, Goretti B, Zipoli V, et al. Reliability, practice effects and change indices for Rao’ s brief repeatable battery. Mult Scler. 2010;16:611–617.
    1. Bingöl A, Yıldız Ş, Topçular B, et al. Brief repeatable battery (BRB) Turkish normative data. Eur J Neurol. 2012;19(Suppl 1):458–807.
    1. Caldirola D, Daccò S, Grassi M, et al. Effects of cigarette smoking on neuropsychological performance in mood disorders: a comparison between smoking and nonsmoking inpatients. J Clin Psychiatry. 2013;74(2):e130–e136.
    1. Yoneda I, Watanabe Y. Comparisons of altitude tolerance and hypoxia symptoms between nonsmokers and habitual smokers. Aviat Space Environ Med. 1997;68(9):807–811.
    1. Chamberlain SR, Odlaug BL, Schreiber LR, Grant JE. Association between tobacco smoking and cognitive functioning in young adults. Am J Addict. 2012;21(1):S14–S19.
    1. Durazzo TC, Meyerhoff DJ, Nixon SJ. Chronic cigarette smoking: implications for neurocognition and brain neurobiology. Int J Environ Res Public Health. 2010;7(10):3760–3091.
    1. Shirani A, Tremlett H. The effect of smoking on the symptoms and progression of multiple sclerosis: a review. J Inflamm Res. 2010;3:115–126.
    1. Sundström P, Nyström L. Smoking worsens the prognosis in multiple sclerosis. Mult Scler. 2008;14(8):1031–1035.
    1. Results of the Global Adult Tobacco Survey [webpage on the Internet] Ankara, Turkey: Republic of Turkey Turkish Statistical Institute; 2012. [Accessed May 24, 2014]. Available from: .
    1. Rao SM, Grafman J, DiGiulio D, et al. Memory dysfunction in multiple sclerosis: Its relation to working memory, semantic encoding, and implicit learning. Neuropsychology. 1993;7(3):364–374.
    1. Brochet B, Deloire MS, Bonnet M, et al. Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study. Mult Scler. 2008;14(9):1242–1249.
    1. Savettieri G, Messina D, Andreoli V, et al. Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis. J Neurol. 2004;251(10):1208–1214.
    1. Borghi M, Cavallo M, Carletto S, et al. Presence and significant determinants of cognitive impairment in a large sample of patients with multiple sclerosis. PLoS One. 2013;8(7):e69820.
    1. Anstey KJ, von Sanden C, Salim A, O’Kearney R. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol. 2007;166:367–378.
    1. Hedström AK, Bäärnhielm M, Olsson T, Alfredsson L. Exposure to environmental tobacco smoke is associated with increased risk for multiple sclerosis. Mult Scler. 2011;17(7):788–793.
    1. Hedström AK, Hillert J, Olsson T, Alfredsson L. Nicotine might have a protective effect in the etiology of multiple sclerosis. Mult Scler. 2013;19(8):1009–1013.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться